AZTA Insider Trading

Insider Ownership Percentage: 10.62%
Insider Buying (Last 12 Months): $997,067.16
Insider Selling (Last 12 Months): $126,689.21

Azenta Insider Trading History Chart

This chart shows the insider buying and selling history at Azenta by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3-$500k$0$500kTotal Insider BuyingTotal Insider Selling

Azenta Share Price & Price History

Current Price: $31.43
Price Change: Price Decrease of -1.416 (-4.31%)
As of 07/3/2025 03:47 PM ET

This chart shows the closing price history over time for AZTA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
AugSepOctNovDecJanFebMarAprMayJunJul$31.43Closing price on 07/05/25:

SEC Filings (Institutional Ownership Changes) for Azenta (NASDAQ:AZTA)

99.08% of Azenta stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AZTA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$328kbought$0soldQ3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3-$1B-$500M$0$500M$1BTotal InflowsTotal Outflows
Azenta logo
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
Read More on Azenta

Today's Range

Now: $31.43
Low: $31.83
High: $33.48

50 Day Range

MA: $28.54
Low: $25.30
High: $32.85

52 Week Range

Now: $31.43
Low: $23.91
High: $63.58

Volume

543,408 shs

Average Volume

735,375 shs

Market Capitalization

$1.44 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.64

Who are the company insiders with the largest holdings of Azenta?

Azenta's top insider shareholders include:
  1. John Marotta (CEO)
  2. David C Gray (Insider)
  3. Herman Cueto (CFO)
  4. Olga Pirogova (SVP)
  5. William L Cornog (Director)
  6. Violetta Hughes (CAO)
Learn More about top insider investors at Azenta.

Who are the major institutional investors of Azenta?

Azenta's top institutional shareholders include:
  1. Kera Capital Partners Inc. — 0.02%
Learn More about top institutional investors of Azenta stock.

Which institutional investors are buying Azenta stock?

In the last quarter, AZTA stock was purchased by institutional investors including:
  1. Kera Capital Partners Inc.
In the previous year, these company insiders have bought Azenta stock:
  1. John Marotta (CEO)
  2. David C Gray (Insider)
Learn More investors buying Azenta stock.